• October 13, 2026
The University of Waterloo’s School of Optometry Unites Vision Researchers Through Its Newly Launched Vision Science Consortium

The University of Waterloo’s School of Optometry and Vision Science is proud to announce the…

  • October 12, 2026
Bausch + Lomb Advances Novel Oral Treatment for Dry AMD Following Constructive FDA Meeting

Bausch + Lomb Corporation announced progress in the development of BL1243 (tonabersat), an investigational oral…

  • October 12, 2026
CooperVision Research Reveals High Receptiveness to Multifocal Contact Lenses for Anti-Aging Benefits

New research from CooperVision reveals that vision remains an overlooked, yet high potential part of…

  • October 11, 2026
The evolution of Blackfin One: Chromatic identity and attention to detail

Obsessive attention to detail and a single-minded drive to achieve excellence are reflected in the…

  • October 10, 2026
Transitions Launches 2026 Students of Vision Scholarship Program in Canada

The Students of Vision Scholarship Program, presented by Transitions® Optical in collaboration with the Opticians…

  • September 29, 2026
EssilorLuxottica and Meta Expand AI Glasses Lineup with Ray-Ban Meta Gen 3 and Audio-Only Frames

EssilorLuxottica and Meta Platforms, the partnership behind the fast-growing smart eyewear category, unveiled the next…

  • September 29, 2026
SILMO Paris 2026 Wrap-Up: Key Highlights, Winners, and Innovation Trends

For four days, SILMO Paris once again set the pulse of the international optics and…

  • September 29, 2026
MIDO 2027: Visitor Registration Is Now Open

Registration is now open for visitors and journalists attending MIDO 2027, scheduled to take place…

  • September 27, 2026
CooperVision Opens New Global Innovation Hub and Unveils Six Major Product Pipelines

CooperVision unveiled the grand opening of The Vision Centre, the company's new global innovation hub…

  • September 22, 2026
Essilor Stellest Lenses Achieve Record Six-Month Results in Latest Clinical Study

EssilorLuxottica is proud to announce significant six-month interim results from an ongoing randomized, double-masked clinical…